Please login to the form below

Not currently logged in
Email:
Password:

Synovate appoints head of oncology in US

Synovate has appointed Jackie Ilacqua to the newly created role of head of oncology

The healthcare division of global market intelligence company, Synovate, has appointed Jackie Ilacqua to the newly created role of head of oncology.

Formerly responsible for building and managing Synovate's global oncology monitor, Ilacqua, based in the US, is now tasked with continuing to develop the agency's portfolio of services within oncology.

This includes maximising the potential of the company's extensive oncology expertise across both its syndicated and custom research businesses. Ilacqua will also drive the creation of new oncology services in the areas of sales force effectiveness; forecasting; the agency's key opinion leader work; advanced analytics; and oncology market modelling.

Ilacqua joined Synovate (then Tandem Research) in 1991. She has more than 18 years of therapy area research experience, the last four of which have been solely dedicated to oncology.

Bob Douglas, global head of Synovate healthcare said: "Oncology is the largest pharmaceutical market in the world and continues to show good growth. Our recent expansion of our global oncology monitor is testament to that. Jackie's appointment to this role is a demonstration of our commitment to this important field of research – she has the oncology experience and extensive know-how to ensure that we are delivering the best the industry has to offer in this area, on both a global and local market level."

Ilacqua will continue to lead Synovate's global oncology monitor.

19th October 2009

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Wordbird

Wordbird is a healthcare communications agency with creative, compelling copy at its heart....

Latest intelligence

Report: Achieving launch excellence in the challenging healthcare markets of today
Our in-depth report is based on original data and expert interviews, which coupled with our own experience, ensures we give you the best recommendations for achieving launch success in challenging...
What is blockchain and why should i care - Richard Springham
Four Health - Emerging Technologies The power of blockchain lies in the fact it can prove that a unique event occurred at a certain time with out the need to...
NHS medicines optimisation milestone
Steve How, Paul Midgley and Oli Hudson, of the Wilmington Healthcare Consulting Team, explore the implications of Adalimumab’s recent European patent expiry...

Infographics